Skip to main content
. 2023 Apr 26;30(7):4249–4259. doi: 10.1245/s10434-023-13468-6

Table 2.

Time to treatment initiation of any treatment modality based on clinical stage at diagnosis comparing Pre-COVID and COVID periods

Pre-COVID (Median, IQR) COVID (Median, IQR) P-value
TTI for all patients (days) n=23,922 51 (30–83) 49 (29–78) < 0.0001
TTI for stage I (days) n=9666 56 (33–88) 53 (33–82) 0.0235
TTI for stage II (days) n=5785 58 (35–92) 57 (34–91) 0.1538
TTI for stage III (days) n=4987 48 (28–77) 45 (28–76) 0.1186
TTI for stage IV (days) n=3484 36 (20–61) 34 (21–56) 0.1027

TTI: Time to treatment initiation.